The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
27 June 2025
Cel AI PLC
("Cel AI" or "the Company")
Changes in Board Composition
Cel AI (LSE: CLAI) announces that Nicholas Lyth has resigned as Chief Financial Officer of the Company, and Matt Lodge has resigned as a non executive director with immediate effect.
The Board would like to take this opportunity to thank Mr. Lyth and Mr. Lodge for their respective contributions to the Company and wish them well for the future.
The Company is pleased to announce that Elliot Fielding has been appointed as Chief Financial Officer. The appointment will take effect immediately.
Elliot Fielding qualified as a Chartered Accountant at Deloitte, with experience in Audit and Transaction Services. Elliot has advised clients ranging from large multinational and listed companies to smaller, privately owned and managed operations, in various sectors including law, TMT, real estate, sport and travel. Currently, he is the managing partner of Sampson Fielding, a firm of Chartered Accountants and Business Advisors. Elliot was previously a director of AQSE-listed Flex Labs Inc.
| | Current directorships and/or partnerships: | Former directorships and/or partnerships (within the last five years): |
| Elliot Fielding | Sampson Fielding Ltd Sampson Fielding Audit Services Ltd Accounting Flow Ltd Bartrum Lerner Limited | Flex Labs Inc Daxiom Ltd |
Were UKLR 6.4.8 to apply to the Company, there would be no further information to disclose.
For further information, please contact:
| Cel AI |
|
| Director Olivia Edwards |
via FSCF |
| First Sentinel Corporate Finance (FSCF) |
|
| Corporate Advisor Brian Stockbridge |
+44 7858 888 007 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
